ADHD

FDA Approves Novel Nonstimulant Treatment for Pediatric ADHD

The US Food and Drug Administration has approved Supernus Pharmaceuticals’ Qelbree for the treatment of attention-deficit hyperactivity disorder (ADHD) in patients aged 6 to 17 years.

Video Game Improves Pediatric ADHD With or Without Medication

The digital therapeutic treatment AKL-T01 significantly improved attention-deficit/hyperactivity disorder (ADHD) symptoms and related impairments in both children who used, and did not use, stimulant medication.

Green Environments in Early Childhood Appear to Influence ADHD Risk

Less green space surrounding a child’s home may be associated with a higher risk of developing attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Environmental Health Perspectives.

Childhood ADHD May Increase Risk of Subsequent Psychotic Disorders

Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) may have an increased risk of a subsequent psychotic disorder (PD), according to a meta-analysis recently published online in JAMA Psychiatry.

Machine Learning Model Detects ADHD With High Accuracy

Task-based functional connectivity can serve as a biomarker for attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Frontiers in Physiology.

FDA Action on SPN-812 Expected in April

The US Food and Drug Administration has classified the resubmission of the New Drug Application for SPN-812 as Class I, setting early April as the Prescription Drug User Fee Act target action date, Supernus Pharmaceuticals, Inc. announced.

Holidays During a Pandemic: Challenges Faced by Youth With ADHD

Adelaide Robb, MD, discusses the challenges faced by children and adolescents with attention-deficit/hyperactivity disorder during the 2020 holiday season, amid the COVID-19 pandemic.

Coping With Holiday Stress: Positive Emotions to the Rescue

Saundra Jain, MA, PsyD, LPC, shares coping skills and practices which clinicians can use to cope with stress during the holiday season and other challenging times.

Fewer ADHD Symptoms Seen in Girls Active in Youth Sports

Consistent participation in extracurricular sports during the elementary school years predicted fewer attention-deficit/hyperactivity disorder (ADHD) symptoms at age 12 in girls—but not in boys, according to a study in Preventive Medicine.

Genetic Differences Identified in African American Children With ADHD

Children with attention-deficit/hyperactivity disorder (ADHD) who are African American appear to have key genetic differences from those who are Caucasian, according to a study published in Scientific Reports.

Investigational Stimulant Improves ADHD Symptoms in Phase 3 Trial

AR19, an investigational stimulant for attention-deficit/hyperactivity disorder (ADHD), improved symptoms in adults with ADHD in a Phase 3 trial, according to a poster presented at Psych Congress 2020.

Videos

Holidays During a Pandemic: Challenges Faced by Youth With ADHD

Adelaide Robb, MD, discusses the challenges faced by children and adolescents with attention-deficit/hyperactivity disorder during the 2020 holiday season, amid the COVID-19 pandemic.